Stealth-Body Technology
Making Breakthrough Discoveries
Making Breakthrough Discoveries
with Stealth-Body Technology
Smart Cell Targeting
Stealth-Body
Proprietary Fc mutations that switch off effector function while leaving antigen binding intact.
Across the Fc gamma receptor panel, it shows no binding and no effector activity above background.
Effector engagement is one way an antibody acts on tissue it was never aimed at. Closing that route matters most when the antibody is carrying a payload.
See how Stealth-Body works
3 min 24 sec · English subtitles
Mission
Key to the success of
Key to the success of
novel drug development
CrossPoint Therapeutics strives to develop drugs that expands the range of curable disease as well as providing dignity and better life to patients.
More →
News & Media
Read more →
In press media
Check out the latest news about our company below.
Contact
Get in touch